Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;20(1):83-89.
doi: 10.1007/s12663-019-01309-7. Epub 2019 Nov 20.

Is Salivary Sialic Acid a Reliable Biomarker in the Detection of Oral Potentially Malignant Disorder and Oral Squamous Cell Carcinoma

Diana Daniel  1 , Jerin Jose  1 , A Harish Kumar  1
Affiliations

Is Salivary Sialic Acid a Reliable Biomarker in the Detection of Oral Potentially Malignant Disorder and Oral Squamous Cell Carcinoma

Diana Daniel et al. J Maxillofac Oral Surg. 2021 Mar.

Abstract

Purpose: Glycoprotein is an important constituent of saliva, and the observed increase in salivary glycoproteins such as sialic acid in oral potentially malignant disorder (OPMDs) and OSCC has stimulated the interest of researchers to explore it as a possible biomarker.

Methods: The study used 60 subjects, who were divided into three groups: Group I-20 subjects who were clinically and histopathologically diagnosed with OSCC; Group II-20 subjects who were clinically and histopathologically diagnosed with OPMDs; and Group III-20 healthy subjects with good oral hygiene and with no systemic disorders detected. Two millilitres of unstimulated salivary samples was collected in a pre-sterilized container to analyse total salivary sialic acid (TSA) levels using a sialic acid kit and UV spectrophotometer.

Results: The TSA levels in OSCC (545.45 ± 100.04) were much higher when compared to the level in OPMDs (169.80 ± 66.43) and in healthy subjects (25.45 ± 16.07). Statically significant correlation was observed between different grades of OSCC. Moreover, sialic acid showed 100% sensitivity and specificity between all the three groups. Statistical analysis was done with Kruskal-Wallis, followed by Mann-Whitney post hoc test at P < 0.05. The results suggested the utility of sialic acid as an efficient biomarker.

Keywords: Biomarkers; Oral potentially malignant disorder (OPMDs); Oral squamous cell carcinoma (OSCC); Saliva; Total sialic acid level (TSA).

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that we have no conflict of interest.

Figures

Fig. 1
Fig. 1
Showing UV spectrophotometer, pre-sterilized container with saliva samples, centrifugation machine, centrifuge, automated micropipettes and pink-coloured solution
Fig. 2
Fig. 2
Graph showing ROC curve for OSCC and OPMDs groups
See this image and copyright information in PMC

References

    1. Jacob TV, Ramesh M, Murali S, Ramesh K, Sanjay PR, Abraham P. A non-invasive study to estimate and compare salivary sialic acid level as tumor marker in patients with precancer and oral cancer. J Cancer Res Ther. 2016;12:634–639. doi: 10.4103/0973-1482.148697. - DOI - PubMed
    1. Rajpura KB, Patel PS, Chawda JG, Shah RM. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer. J Oral Pathol Med. 2005;34:263–267. doi: 10.1111/j.1600-0714.2004.00210.x. - DOI - PubMed
    1. Sanjay PR, Hallikeri K, Shivashankara AR. Evaluation of salivary sialic acid, total protein and total sugar in oral cancer: a preliminary report. Indian J Dent Res. 2008;19:288–291. doi: 10.4103/0970-9290.44529. - DOI - PubMed
    1. Chan DW, Schwartz MK. Tumor markers. In: Diamandis EP, Fritsche HA, Lilja H, Chan DW, Schwartz MK, editors. Physiology, pathobiology, technology, and clinical applications. Tumor markers: introduction and general principles. Washington: AACC Press; 2002. pp. 9–17.
    1. Segal A, Wong DT. Salivary diagnostics: enhancing disease detection and making medicine better. Eur J Dent Educ. 2008;12:22–29. doi: 10.1111/j.1600-0579.2007.00477.x. - DOI - PMC - PubMed

LinkOut - more resources